D
Biosenta Inc.
ZRO
CNSX
D
Sell
3/25/2024Upgraded
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 3/25/2024 due to an increase in the volatility index, total return index and valuation index.
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 3/25/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
3/7/2024Downgrade
Biosenta Inc. (ZRO) was downgraded to E+ from D- on 3/7/2024 due to a decline in the volatility index, growth index and valuation index. Operating cash flow declined 175.43% from -$92.8 to -$255.6, and total revenue declined 66.67% from $300 to $100.
Biosenta Inc. (ZRO) was downgraded to E+ from D- on 3/7/2024 due to a decline in the volatility index, growth index and valuation index. Operating cash flow declined 175.43% from -$92.8 to -$255.6, and total revenue declined 66.67% from $300 to $100.
D
Sell
3/1/2024Upgraded
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 3/1/2024 due to an increase in the volatility index.
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 3/1/2024 due to an increase in the volatility index.
E
Sell
2/15/2024Downgrade
Biosenta Inc. (ZRO) was downgraded to E+ from D- on 2/15/2024 due to a decline in the volatility index, total return index and valuation index.
Biosenta Inc. (ZRO) was downgraded to E+ from D- on 2/15/2024 due to a decline in the volatility index, total return index and valuation index.
D
Sell
1/31/2024Upgraded
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 1/31/2024 due to an increase in the valuation index.
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 1/31/2024 due to an increase in the valuation index.
E
Sell
12/27/2023Downgrade
Biosenta Inc. (ZRO) was downgraded to E+ from D- on 12/27/2023 due to a noticeable decline in the total return index and volatility index.
Biosenta Inc. (ZRO) was downgraded to E+ from D- on 12/27/2023 due to a noticeable decline in the total return index and volatility index.
D
Sell
9/1/2023Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from C- on 9/1/2023 due to a significant decline in the efficiency index, valuation index and growth index. Operating cash flow declined 100.99% from -$60.8 to -$122.2, earnings per share declined from -$0.0108 to -$0.016, and net income declined 47.83% from -$249 to -$368.1.
Biosenta Inc. (ZRO) was downgraded to D- from C- on 9/1/2023 due to a significant decline in the efficiency index, valuation index and growth index. Operating cash flow declined 100.99% from -$60.8 to -$122.2, earnings per share declined from -$0.0108 to -$0.016, and net income declined 47.83% from -$249 to -$368.1.
C
Hold
8/3/2023Upgraded
Biosenta Inc. (ZRO) was upgraded to C- from D+ on 8/3/2023 due to an increase in the valuation index, volatility index and total return index.
Biosenta Inc. (ZRO) was upgraded to C- from D+ on 8/3/2023 due to an increase in the valuation index, volatility index and total return index.
D
Sell
7/19/2023Downgrade
Biosenta Inc. (ZRO) was downgraded to D+ from C- on 7/19/2023 due to a decline in the valuation index, volatility index and total return index.
Biosenta Inc. (ZRO) was downgraded to D+ from C- on 7/19/2023 due to a decline in the valuation index, volatility index and total return index.
C
Hold
6/5/2023Upgraded
Biosenta Inc. (ZRO) was upgraded to C- from D- on 6/5/2023 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 54.18% from -$132.7 to -$60.8.
Biosenta Inc. (ZRO) was upgraded to C- from D- on 6/5/2023 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 54.18% from -$132.7 to -$60.8.
D
Sell
3/14/2023Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from D on 3/14/2023 due to a major decline in the growth index, total return index and valuation index. Earnings per share declined from $0.0208 to -$0.0077, total revenue declined 33.33% from $300 to $200, and operating cash flow declined 14.1% from -$116.3 to -$132.7.
Biosenta Inc. (ZRO) was downgraded to D- from D on 3/14/2023 due to a major decline in the growth index, total return index and valuation index. Earnings per share declined from $0.0208 to -$0.0077, total revenue declined 33.33% from $300 to $200, and operating cash flow declined 14.1% from -$116.3 to -$132.7.
D
Sell
2/23/2023Upgraded
Biosenta Inc. (ZRO) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
Biosenta Inc. (ZRO) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
Biosenta Inc. (ZRO) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
5/5/2022Upgraded
Biosenta Inc. (ZRO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
Biosenta Inc. (ZRO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell
4/20/2022Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
Biosenta Inc. (ZRO) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index.
D
Sell
11/23/2021Upgraded
Biosenta Inc. (ZRO) was upgraded to D from D- on 11/23/2021.
Biosenta Inc. (ZRO) was upgraded to D from D- on 11/23/2021.
D
Sell
11/8/2021Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from D on 11/8/2021 due to a significant decline in the total return index, growth index and volatility index. Total revenue declined 99.54% from $107.6 to $500, EBIT declined 95.48% from -$366.9 to -$717.2, and earnings per share declined from -$0.0217 to -$0.0414.
Biosenta Inc. (ZRO) was downgraded to D- from D on 11/8/2021 due to a significant decline in the total return index, growth index and volatility index. Total revenue declined 99.54% from $107.6 to $500, EBIT declined 95.48% from -$366.9 to -$717.2, and earnings per share declined from -$0.0217 to -$0.0414.
D
Sell
5/1/2020Downgrade
Biosenta Inc. (ZRO) was downgraded to D from D+ on 5/1/2020 due to a major decline in the efficiency index.
Biosenta Inc. (ZRO) was downgraded to D from D+ on 5/1/2020 due to a major decline in the efficiency index.
D
Sell
4/16/2020Upgraded
Biosenta Inc. (ZRO) was upgraded to D+ from D on 4/16/2020 due to a significant increase in the total return index, growth index and volatility index. Operating cash flow increased 85.93% from -$133.6 to -$18.8.
Biosenta Inc. (ZRO) was upgraded to D+ from D on 4/16/2020 due to a significant increase in the total return index, growth index and volatility index. Operating cash flow increased 85.93% from -$133.6 to -$18.8.
D
Sell
2/4/2020Downgrade
Biosenta Inc. (ZRO) was downgraded to D from C- on 2/4/2020 due to a significant decline in the efficiency index, growth index and valuation index. Operating cash flow declined 518.52% from -$21.6 to -$133.6, net income declined 31.37% from -$89.9 to -$118.1, and earnings per share declined from -$0.0064 to -$0.0084.
Biosenta Inc. (ZRO) was downgraded to D from C- on 2/4/2020 due to a significant decline in the efficiency index, growth index and valuation index. Operating cash flow declined 518.52% from -$21.6 to -$133.6, net income declined 31.37% from -$89.9 to -$118.1, and earnings per share declined from -$0.0064 to -$0.0084.
C
Hold
1/27/2020Upgraded
Biosenta Inc. (ZRO) was upgraded to C- from D+ on 1/27/2020 due to a significant increase in the efficiency index, growth index and volatility index. Operating cash flow increased 59.32% from -$53.1 to -$21.6, net income increased 28.48% from -$125.7 to -$89.9, and earnings per share increased from -$0.0089 to -$0.0064.
Biosenta Inc. (ZRO) was upgraded to C- from D+ on 1/27/2020 due to a significant increase in the efficiency index, growth index and volatility index. Operating cash flow increased 59.32% from -$53.1 to -$21.6, net income increased 28.48% from -$125.7 to -$89.9, and earnings per share increased from -$0.0089 to -$0.0064.
D
Sell
8/2/2019Upgraded
Biosenta Inc. (ZRO) was upgraded to D+ from D on 8/2/2019 due to a significant increase in the total return index, efficiency index and growth index. EBIT increased 8.62% from -$42.9 to -$39.2.
Biosenta Inc. (ZRO) was upgraded to D+ from D on 8/2/2019 due to a significant increase in the total return index, efficiency index and growth index. EBIT increased 8.62% from -$42.9 to -$39.2.
D
Sell
9/7/2018Upgraded
Biosenta Inc. (ZRO) was upgraded to D from D- on 9/7/2018 due to an increase in the efficiency index, volatility index and growth index. EBIT increased 23.26% from -$55.9 to -$42.9, and operating cash flow increased 0.4% from -$49.6 to -$49.4.
Biosenta Inc. (ZRO) was upgraded to D from D- on 9/7/2018 due to an increase in the efficiency index, volatility index and growth index. EBIT increased 23.26% from -$55.9 to -$42.9, and operating cash flow increased 0.4% from -$49.6 to -$49.4.
D
Sell
6/5/2018Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from D on 6/5/2018 due to a noticeable decline in the growth index, efficiency index and valuation index. Operating cash flow declined 138.46% from -$20.8 to -$49.6, and EBIT declined 5.67% from -$52.9 to -$55.9.
Biosenta Inc. (ZRO) was downgraded to D- from D on 6/5/2018 due to a noticeable decline in the growth index, efficiency index and valuation index. Operating cash flow declined 138.46% from -$20.8 to -$49.6, and EBIT declined 5.67% from -$52.9 to -$55.9.
D
Sell
3/15/2018Upgraded
Biosenta Inc. (ZRO) was upgraded to D from D- on 3/15/2018 due to an increase in the growth index. Earnings per share increased from -$0.0582 to -$0.0046, operating cash flow increased 86.62% from -$155.4 to -$20.8, and EBIT increased 53.23% from -$113.1 to -$52.9.
Biosenta Inc. (ZRO) was upgraded to D from D- on 3/15/2018 due to an increase in the growth index. Earnings per share increased from -$0.0582 to -$0.0046, operating cash flow increased 86.62% from -$155.4 to -$20.8, and EBIT increased 53.23% from -$113.1 to -$52.9.
D
Sell
3/14/2018Downgrade
Biosenta Inc. (ZRO) was downgraded to D- from D on 3/14/2018 due to a major decline in the growth index, solvency index and total return index. Earnings per share declined from $0.0025 to -$0.0582, debt to equity increased from 0.49 to 2.49, and operating cash flow declined 368.39% from $57.9 to -$155.4.
Biosenta Inc. (ZRO) was downgraded to D- from D on 3/14/2018 due to a major decline in the growth index, solvency index and total return index. Earnings per share declined from $0.0025 to -$0.0582, debt to equity increased from 0.49 to 2.49, and operating cash flow declined 368.39% from $57.9 to -$155.4.
D
Sell
8/25/2017Downgrade
Biosenta Inc. (ZRO) was downgraded to D from C- on 8/25/2017 due to a significant decline in the valuation index and efficiency index. Total capital declined 1.15% from $1.33M to $1.32M.
Biosenta Inc. (ZRO) was downgraded to D from C- on 8/25/2017 due to a significant decline in the valuation index and efficiency index. Total capital declined 1.15% from $1.33M to $1.32M.
C
Hold
8/15/2017Upgraded
Biosenta Inc. (ZRO) was upgraded to C- from D+ on 8/15/2017 due to a noticeable increase in the total return index.
Biosenta Inc. (ZRO) was upgraded to C- from D+ on 8/15/2017 due to a noticeable increase in the total return index.
D
Sell
6/22/2017Upgraded
Biosenta Inc. (ZRO) was upgraded to D+ from D on 6/22/2017 due to a significant increase in the valuation index.
Biosenta Inc. (ZRO) was upgraded to D+ from D on 6/22/2017 due to a significant increase in the valuation index.
D
Sell
11/1/2016Upgraded
Biosenta Inc. (ZRO) was upgraded to D from D- on 11/1/2016 due to a significant increase in the efficiency index, volatility index and solvency index. Net income increased 1,420.44% from -$191.8 to $2.53M, total capital increased 279.34% from $353.3 to $1.34M, and the quick ratio increased from 0.01 to 0.02.
Biosenta Inc. (ZRO) was upgraded to D from D- on 11/1/2016 due to a significant increase in the efficiency index, volatility index and solvency index. Net income increased 1,420.44% from -$191.8 to $2.53M, total capital increased 279.34% from $353.3 to $1.34M, and the quick ratio increased from 0.01 to 0.02.
D
Sell
7/1/2016Upgraded
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 7/1/2016 due to a large increase in the total return index and efficiency index.
Biosenta Inc. (ZRO) was upgraded to D- from E+ on 7/1/2016 due to a large increase in the total return index and efficiency index.
E
Sell
6/3/2016Upgraded
Biosenta Inc. (ZRO) was upgraded to E+ from E on 6/3/2016 due to a noticeable increase in the volatility index.
Biosenta Inc. (ZRO) was upgraded to E+ from E on 6/3/2016 due to a noticeable increase in the volatility index.
E
Sell
5/3/2016Downgrade
Biosenta Inc. (ZRO) was downgraded to E from E+ on 5/3/2016 due to a substantial decline in the volatility index.
Biosenta Inc. (ZRO) was downgraded to E from E+ on 5/3/2016 due to a substantial decline in the volatility index.
E
Sell
4/1/2016Upgraded
Biosenta Inc. (ZRO) was upgraded to E+ from E on 4/1/2016 due to a large increase in the total return index and growth index. Earnings per share increased from -$0.0116 to -$0.0025, EBIT increased 61.02% from -$441.5 to -$172.1, and total revenue increased 1.46% from $27.4 to $27.8.
Biosenta Inc. (ZRO) was upgraded to E+ from E on 4/1/2016 due to a large increase in the total return index and growth index. Earnings per share increased from -$0.0116 to -$0.0025, EBIT increased 61.02% from -$441.5 to -$172.1, and total revenue increased 1.46% from $27.4 to $27.8.
E
Sell
1/20/2016None
Biosenta Inc. (ZRO) was downgraded to E from U on 01/20/2016.
Biosenta Inc. (ZRO) was downgraded to E from U on 01/20/2016.
